Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Thursday, 20 June 2013
Page: 6500

Chemotherapy Drugs

Debate resumed on the motion:

That this House:

(1) notes the concerns of key stakeholders in relation to the price reduction of chemotherapy drug Docetaxel and its potential broader impact on the treatment of cancer patients;

(2) calls on the Government to:

(a) negotiate with relevant bodies regarding the cost of dispensing chemotherapy drugs; and

(b) ensure that the result of these negotiations will allow pharmacists to continue dispensing the drug, and other chemotherapy drugs, without disrupting patients; and

(3) welcomes the policy of price disclosure of items on the Pharmaceutical Benefits Scheme, however calls on the Government to ensure that further disruptions to patients do not occur.